Navigation Links
Clinical Benefits Demonstrated with Low-Dose GATTEX(TM) in Phase 3 Short Bowel Syndrome Study
Date:10/11/2007

ing, which may provide greater mobility and improved sleep. More information about SBS is available on the website, http://www.shortbowel.com and http://www.glucagon.com.

About GATTEX

A potential first-in-class drug, GATTEX is a proprietary analog of naturally occurring human glucagon-like peptide 2 (GLP-2), a peptide secreted primarily in the distal intestine and involved in the regeneration and repair of the intestinal epithelium. A previous Phase 2 proof-of-concept clinical study in patients with SBS showed that daily subcutaneous injections of GATTEX resulted in significant regeneration of the intestinal lining and improved dietary absorption of nutrients and fluids. Once the company has completed its analysis of data from the Phase 3 SBS study, it expects to pursue a pre-NDA meeting with the U.S. Food and Drug Administration to discuss its potential plan for submitting a New Drug Application. NPS is also pursuing development of GATTEX as a possible treatment for chemotherapy-induced gastrointestinal mucositis in cancer patients and necrotizing enterocolitis in preterm infants.

Conference Call Information

A conference call will be held today at 9:00 a.m. EDT. To participate in the call, dial (866) 770-7125 with passcode 66355061. International callers may dial (617) 213-8066 using the same passcode. In addition, live audio of the conference call will be simultaneously broadcast over the Internet and may be accessed on the company's home page, http://www.npsp.com. A conference call replay will be available until October 22, 2007 at (888) 286-8010, or (617) 801-6888 for international callers, with passcode 47718436. The webcast will be available for replay and iPod(R) download for the same period.

Note: Statements made in this press release, which are not historical in nature, consti
'/>"/>

SOURCE NPS Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Genetic Analysis Systems Enter the Clinical Mainstream
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Large Geographic Differences in EpiPen Prescriptions in the U.S., From the Journal of Allergy and Clinical Immunology
4. Sygnis Pharma AG announces date for presentation of clinical results
5. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
6. Clinical Data Suggest Decreased Bleeding Risk in People With Severe Hemophilia A While Maintaining Factor VIII Levels Above One Percent
7. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
8. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
9. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
10. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
11. Protox Announces Positive Clinical Data from Prostate Cancer Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... -- CVS Caremark Corporation (NYSE: CVS ) today ... dividend of $0.275 (27.5 cents) per share on the corporation,s ... to holders of record on July 21, 2014. ... to helping people on their path to better health as ... States . Through the company,s more than 7,600 CVS/pharmacy ...
(Date:1/15/2014)... Jan. 15, 2014 /PRNewswire-iReach/ -- ChinaMarketResearchReports.com adds "China Orthopedic ... . (Photo: http://photos.prnewswire.com/prnh/20140115/MN46792 ) ... policy support, China,s orthopedic instrument ... total market size rising from 3.28 billion yuan in ...
(Date:1/15/2014)... Jan. 15, 2014 As health officials across the Midwest ... Meijer pharmacies in Michigan will offer ... patients, enabling Meijer pharmacists to administer tests and, in some ... a physician participating in the study. The ...
Breaking Medicine Technology:Orthopedic Instrument Industry in China Markets Forecast to 2015 2Orthopedic Instrument Industry in China Markets Forecast to 2015 3Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 2Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 3
... a voluntary nationwide recall of the three lots listed below of the following product: ... l oi de Injection , USP, 0 . ... V i alsN DC# 0 5 1 ... recall, initiated on March 15, 2011 to the User Level, is for the following lots of ...
... Kinetics, Inc. (NKI) ( www.neuro-kinetics.com ), manufacturers of ... testing, said today that it will showcase its ... with the military to develop earlier diagnosis of ... Awareness Day on Capitol Hill in Washington, D.C. ...
Cached Medicine Technology:American Regent Initiates Voluntary Nationwide Recall of Bacteriostatic Sodium Chloride Injection, USP, 0.9% 30 mL Multiple Dose Vials 2American Regent Initiates Voluntary Nationwide Recall of Bacteriostatic Sodium Chloride Injection, USP, 0.9% 30 mL Multiple Dose Vials 3Neuro Kinetics to Showcase I-Portal® Research at Brain Injury Awareness Day on Capitol Hill 2
(Date:7/11/2014)... The “Proteomics Market by Technology (Protein ... Plasmon Resonance, X-ray Crystallography) - Instruments, Reagents & ... studies the major market drivers, restraints, and opportunities ... of the World (RoW). , The proteomics market ... years, mainly due to the increasing need of ...
(Date:7/11/2014)... the best available treatment for patients, from a range ... for taxpayers than the existing clinical trial process, a ... carried out while he was a member of the ... based at The University of Manchester,s Health eResearch Centre, ... ) today (Friday 11 July) looked at the use ...
(Date:7/11/2014)... With the arrival of summer, VisitandCare.com ... surgery and hair transplant procedures, up 80 percent from ... of medical tourism destinations, the company is helping patients ... and achieve the look they have always desired. ... name in the medical tourism industry, VisitandCare.com is comprised ...
(Date:7/11/2014)... (PRWEB) July 11, 2014 Recently, Fadhits.com, the ... assortment of kids prom dresses . To bring more ... firm has also launched a special offer for these brand ... 25, 2014. , The company’s sales manager says gladly, “We ... this special offer is to acknowledge all new and old ...
(Date:7/11/2014)... Francisco shows that an "expressive therapy" group intervention ... with HIV disclose their health status and improves ... quality of their relationships., "Medication alone is totally ... Machtinger, MD, director of the Women,s HIV Program ... are on effective antiretroviral therapy but far too ...
Breaking Medicine News(10 mins):Health News:Proteomics Market Worth $20,696.4 Million by 2018 - New Report By MarketsandMarkets 2Health News:Proteomics Market Worth $20,696.4 Million by 2018 - New Report By MarketsandMarkets 3Health News:Proteomics Market Worth $20,696.4 Million by 2018 - New Report By MarketsandMarkets 4Health News:Better use of electronic health records makes clinical trials less expensive 2Health News:VisitandCare.com Reports Increase in Cosmetic and Hair Transplant Procedures for Men 2Health News:VisitandCare.com Reports Increase in Cosmetic and Hair Transplant Procedures for Men 3Health News:Promotion for Kids Prom Dresses Now Provided at Fadhits.com 2Health News:'Expressive therapy" intervention assists women living with HIV 2
... , MILLERSVILLE, Md., June 2 Travel Advantage Network ... spring morning to support the National Alliance for Research ... kilometers of it. , , (Photo: http://www.newscom.com/cgi-bin/prnh/20090602/DC26325 ) ... support the charity by completing a 2.5K sponsored walk at ...
... Royal Philips Electronics (NYSE: ... Trilogy100 portable at-home life-support ventilator. The highly versatile, ... milestone in home ventilation from a recognized leader in ... for noninvasive ventilation nearly 20 years ago. , ...
... 2 More than 17 million U.S. children live more ... a life-saving pediatric trauma center, according to a new study ... University of Pennsylvania . The creation of a national ... locations of gaps and greatly improve access to care for ...
... new procedure , TUESDAY, June ... involves sewing together the sides of the stomach holds ... suggest preliminary findings from a clinical trial. , The ... the stomach from relaxing to accept food. This reduces ...
... Pa., June 2 Governor Edward G. Rendell ... the Lottery-funded PACENET prescription drug benefit for older Pennsylvanians, providing ... no drug coverage now. , , "As older ... times, providing comprehensive prescription medication coverage is more important than ...
... Monitor for pest control operators helps control bed bug ... BioSensory, Inc., manufacturer of environmentally-sensitive pest management products ... insects, announces the release of its NightWatch(TM) Bedbug Monitor ... to use to detect bed bug infestations at the ...
Cached Medicine News:Health News:A Little Bit of Leg Work Goes a Long Way for Travel Advantage Network and Mental Health Charity 2Health News:Photos: Philips Expands Home Healthcare Commitment With Portable Life-Support Ventilator; Offers Ease of Use, Portability and Versatility for Patient 2Health News:Photos: Philips Expands Home Healthcare Commitment With Portable Life-Support Ventilator; Offers Ease of Use, Portability and Versatility for Patient 3Health News:17 Million U.S. Children Live More Than an Hour Away From Trauma Care 2Health News:17 Million U.S. Children Live More Than an Hour Away From Trauma Care 3Health News:Weight-Loss Surgery Simplified 2Health News:Governor Rendell Proposes Offering Prescription Help to 30,000 More Older Adults as Part of Plan to Save $60 Million 2Health News:New Product Detects Early Bed Bug Infestations 2Health News:New Product Detects Early Bed Bug Infestations 3
Inquire...
... These high-power, apochromatically corrected ... satisfy the most exacting ... They are suitable for ... to 25 mm and ...
... a higher numerical aperture and superior contrast. ... surface,reflections and provides an image with higher ... fluorescence, brightfield and DIC observation techniques. This ... allows it to be used with immersion ...
The KL 2500 LCD is Schott's most powerful cold light source which makes it ideal for special applications. A 250W halogen reflector lamp provides more than twice as much light as the KL 1500 LCD....
Medicine Products: